bf/NASDAQ:SAGE_icon.jpeg

NASDAQ:SAGE

Sage Therapeutics

  • Stock

USD

Last Close

6.30

12/11 19:57

Market Cap

663.81M

Beta: 1.15

Volume Today

265.79K

Avg: 531.49K

PE Ratio

−2.29

PFCF: −2.65

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
90.27M
-
6.87M
92.39%
1.11B
16,123.06%
6.31M
99.43%
7.69M
21.85%
86.45M
1,024.84%
cost of revenue
400K
-
565K
41.25%
553K
2.12%
813K
47.02%
2.16M
165.56%
gross profit
90.27M
-
6.47M
92.84%
1.11B
17,117.61%
5.75M
99.48%
6.87M
19.43%
84.30M
1,126.48%
selling and marketing expenses
3.08M
-
5.27M
71.26%
11.18M
112.15%
44.60M
299.05%
general and administrative expenses
3.38M
-
9.71M
187.19%
25.29M
160.48%
39.41M
55.80%
62.88M
59.56%
201.40M
220.31%
345.78M
71.68%
196.95M
43.04%
183.50M
6.83%
227.70M
24.09%
274.52M
20.56%
selling general and administrative expenses
3.38M
-
9.71M
187.19%
25.29M
160.48%
39.41M
55.80%
62.88M
59.56%
201.40M
220.31%
345.78M
71.68%
196.95M
43.04%
183.50M
6.83%
227.70M
24.09%
274.52M
20.56%
research and development expenses
14.36M
-
24.10M
67.86%
69.36M
187.79%
120.76M
74.11%
210.28M
74.13%
282.11M
34.16%
368.81M
30.74%
292.71M
20.63%
283.17M
3.26%
326.16M
15.18%
356.24M
9.22%
other expenses
-3K
-
-9K
200%
-23K
155.56%
-35K
52.17%
-64K
82.86%
22K
134.38%
82K
272.73%
250K
204.88%
134K
46.40%
15K
88.81%
-383K
2,653.33%
cost and expenses
18.28M
-
33.81M
84.97%
94.65M
179.95%
160.16M
69.22%
273.15M
70.55%
483.51M
77.01%
714.99M
47.88%
490.23M
31.44%
467.22M
4.69%
554.67M
18.72%
632.92M
14.11%
operating expenses
18.28M
-
33.81M
84.97%
94.65M
179.95%
160.16M
69.22%
273.15M
70.55%
483.51M
77.01%
714.59M
47.79%
489.67M
31.48%
466.66M
4.70%
553.86M
18.69%
630.76M
13.88%
interest expense
8K
-
14.19M
-
ebitda
-18.23M
-
-33.81M
85.44%
-94.65M
179.95%
-160.16M
69.22%
-273.15M
70.55%
-393.24M
43.96%
-708.12M
80.08%
651.71M
192.03%
-460.91M
170.72%
-546.99M
18.68%
-511.68M
6.45%
operating income
-18.28M
-
-33.81M
84.97%
-94.65M
179.95%
-160.16M
69.22%
-273.15M
70.55%
-393.24M
43.96%
-708.12M
80.08%
596.23M
184.20%
-460.91M
177.30%
-546.99M
18.68%
-579.85M
6.01%
depreciation and amortization
47K
-
51K
8.51%
115K
125.49%
281K
144.35%
531K
88.97%
1.14M
115.25%
2.28M
99.74%
55.49M
2,330.40%
4.18M
92.46%
1.12M
73.17%
1.39M
24.15%
total other income expenses net
-9K
-
-23K
155.56%
-35K
52.17%
-64K
82.86%
22K
134.38%
27.89M
126,654.55%
9.85M
64.69%
3.02M
69.36%
14.21M
370.83%
-33.77M
337.73%
income before tax
-33.81M
-
-94.50M
179.48%
-158.99M
68.25%
-270.12M
69.90%
-372.88M
38.04%
-680.24M
82.43%
606.07M
189.10%
-457.89M
175.55%
-532.78M
16.36%
-541.49M
1.63%
income tax expense
2K
-
-59K
3,050%
-293K
396.61%
-1.49M
409.22%
-3.63M
143.30%
20.36M
660.77%
-30.09M
247.80%
15.52M
151.57%
-7.07M
145.53%
-29.52M
317.79%
-5.36M
81.85%
net income
-18.28M
-
-33.81M
84.95%
-94.50M
179.48%
-158.99M
68.25%
-270.12M
69.90%
-372.88M
38.04%
-650.15M
74.36%
606.07M
193.22%
-450.83M
174.38%
-503.27M
11.63%
-541.49M
7.59%
weighted average shs out
16.77M
-
21.57M
28.62%
27.78M
28.76%
33.47M
20.49%
38.10M
13.83%
46.12M
21.06%
50.83M
10.22%
51.98M
2.26%
58.67M
12.86%
59.31M
1.08%
59.84M
0.89%
weighted average shs out dil
24.96M
-
21.57M
13.57%
27.78M
28.76%
33.49M
20.57%
38.11M
13.80%
46.12M
21.01%
50.83M
10.22%
53.00M
4.27%
58.67M
10.69%
59.31M
1.08%
59.84M
0.89%
eps
-1.09
-
-1.57
44.04%
-3.40
116.56%
-4.75
39.71%
-7.09
49.26%
-8.08
13.96%
-12.79
58.29%
11.66
191.16%
-7.68
165.87%
-8.49
10.55%
-9.05
6.60%
epsdiluted
-0.73
-
-1.57
115.07%
-3.40
116.56%
-4.75
39.71%
-7.09
49.26%
-8.08
13.96%
-12.79
58.29%
11.43
189.37%
-7.68
167.19%
-8.49
10.55%
-9.05
6.60%

All numbers in USD (except ratios and percentages)